Please login to the form below

Not currently logged in
Email:
Password:

Indian generic drug firm expands in Russia

India-based Dr Reddy's Laboratories is to acquire the pharmaceutical prescription portfolio of JB Chemicals & Pharmaceuticals in Russia and other CIS nations

India-based Dr Reddy's Laboratories is to acquire the pharmaceutical prescription portfolio of JB Chemicals & Pharmaceuticals in Russia and other CIS nations.

Dr Reddy's will pay $34.85m to acquire the marketing licences for 20 brands, including Metrogyl (metronidazole) for infections and antihistamine Jocet (cetirizine).

Dr Reddy's has also entered into a supply agreement with JB Chemicals for the continued manufacturing and supply of these products associated with the acquired brands.

"Russia is one of our leading markets where we enjoy a strong equity with stakeholders," said Satish Reddy, MD of Dr Reddy's. "This acquisition will help expand our prescription, hospital and OTC portfolio, complement our existing strong basket of products and add to our growth aspirations in the Russia and other CIS region."

Related links

Find out more about the importance of Russia as a market for the pharmaceutical industry at
Russia: The inside story - the first of PMGroup's Country Report Live events.

 

25th July 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics